mesalamine has been researched along with myricetin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, F; Li, W; Ma, M; Qu, X; Song, Z; Wang, F; Wang, S; Yang, C; Zhang, L; Zhao, J; Zhu, S | 1 |
| Cui, SX; Hu, XT; Miao, RR; Qu, XJ; Wu, LJ; Yuan, WM; Zhan, S | 1 |
2 other study(ies) available for mesalamine and myricetin
| Article | Year |
|---|---|
Development of M10, myricetin-3-O-β-d-lactose sodium salt, a derivative of myricetin as a potent agent of anti-chronic colonic inflammation.
Topics: Animals; Anti-Inflammatory Agents; Colitis, Ulcerative; Colon; Dextran Sulfate; Drug Stability; Female; Flavonoids; Glycosylation; Half-Life; Lactose; Male; Mice, Inbred C57BL; Microsomes, Liver; Rats, Wistar; Solubility | 2019 |
Myricetin and M10, a myricetin-3-O-β-d-lactose sodium salt, modify composition of gut microbiota in mice with ulcerative colitis.
Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bacteria; Colitis, Ulcerative; Dextran Sulfate; Flavonoids; Gastrointestinal Microbiome; Hydroxyquinolines; Male; Mesalamine; Mice; Mice, Inbred C57BL; RNA, Bacterial | 2021 |